The Strait of Hormuz closure is impacting Asia's chemical industry, pushing India to emulate China's coal-to-chemicals model for energy and...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...

Air India is embracing artificial intelligence to transform its operations. The airline is using AI to cut costs, improve customer service ...

US stock market today shows a sharp split. Dow Jones futures fall over 120 points. Nasdaq futures jump nearly 1%. S&P 500 futures edge high...

The US accuses China of stealing AI intellectual property, escalating the tech rivalry beyond tariffs. This move, potentially impacting chi...

The WTO ministerial conference in Yaounde concluded without agreement on crucial trade issues. Key among these was the e-commerce import du...

WTO talks: The talks at a WTO meeting in Cameroon were seeking to bridge differences over extending the e-commerce moratorium, and agree to...

The India-UK free trade agreement safeguards the interests of the Indian generic drugs industry. It does not allow patent extensions or dat...

The India-UK free trade agreement safeguards the domestic generic drug industry. It avoids patent term extensions and data exclusivity. Thi...

The U.S. Defense Department, NASA, and other agencies funded research resulting in over 1,000 U.S. patents for China-based inventors since ...

Japan is pushing for patents to be granted for incremental innovations, even if they don’t show any improved efficacy over an existing inve...

RCEP is a proposed free trade agreement among the 10-member Association of Southeast Asian Nations and Australia, China, India, Japan, Sout...

Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40 countries.

Indian patenting system needs to be improved for faster approvals, N N Prasad, Executive Director, WIPO, said here today.

HSBC has reiterated its 'Overweight' rating on Dr Reddy's Lab and set a target price of 1,950.

The PMO does not plan to seek any changes in two out of four key controversial provisions of the Indian patent law, which can compromise lo...